Julika Ribbat‐Idel

1.1k total citations
42 papers, 638 citations indexed

About

Julika Ribbat‐Idel is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Julika Ribbat‐Idel has authored 42 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 11 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Julika Ribbat‐Idel's work include Cancer Immunotherapy and Biomarkers (15 papers), Head and Neck Cancer Studies (7 papers) and Immunotherapy and Immune Responses (5 papers). Julika Ribbat‐Idel is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Head and Neck Cancer Studies (7 papers) and Immunotherapy and Immune Responses (5 papers). Julika Ribbat‐Idel collaborates with scholars based in Germany, United States and France. Julika Ribbat‐Idel's co-authors include Sven Perner, Christian Idel, Anne Offermann, Jutta Kirfel, Barbara Wollenberg, Christoph Thorns, Rainer Kuefer, Axel S. Merseburger, Rosemarie Krupar and Dirk Rades and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Julika Ribbat‐Idel

38 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julika Ribbat‐Idel Germany 14 270 225 193 147 143 42 638
Jinbo Yue China 16 387 1.4× 152 0.7× 215 1.1× 139 0.9× 111 0.8× 61 748
Thore Thiesler Germany 14 324 1.2× 156 0.7× 228 1.2× 94 0.6× 192 1.3× 31 682
Roshal R. Patel United States 14 596 2.2× 129 0.6× 343 1.8× 104 0.7× 237 1.7× 44 941
Austin Doyle United States 15 423 1.6× 413 1.8× 311 1.6× 99 0.7× 215 1.5× 33 1.0k
Ping Han China 17 168 0.6× 240 1.1× 166 0.9× 134 0.9× 192 1.3× 67 791
Qingting Huang China 12 99 0.4× 158 0.7× 123 0.6× 112 0.8× 59 0.4× 40 444
Daniel Buergy Germany 13 289 1.1× 157 0.7× 152 0.8× 143 1.0× 60 0.4× 29 674
Kensei Nakata Japan 14 232 0.9× 126 0.6× 125 0.6× 59 0.4× 52 0.4× 30 506
Mayra Ramos Cuba 16 461 1.7× 180 0.8× 297 1.5× 60 0.4× 92 0.6× 33 827
Ghassan Allo Canada 16 194 0.7× 334 1.5× 172 0.9× 227 1.5× 36 0.3× 29 796

Countries citing papers authored by Julika Ribbat‐Idel

Since Specialization
Citations

This map shows the geographic impact of Julika Ribbat‐Idel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julika Ribbat‐Idel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julika Ribbat‐Idel more than expected).

Fields of papers citing papers by Julika Ribbat‐Idel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julika Ribbat‐Idel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julika Ribbat‐Idel. The network helps show where Julika Ribbat‐Idel may publish in the future.

Co-authorship network of co-authors of Julika Ribbat‐Idel

This figure shows the co-authorship network connecting the top 25 collaborators of Julika Ribbat‐Idel. A scholar is included among the top collaborators of Julika Ribbat‐Idel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julika Ribbat‐Idel. Julika Ribbat‐Idel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Köster, Frank, Karen Bräutigam, Achim Rody, et al.. (2025). Prognostic and clinical heterogeneity of PD1 and PD-L1- immunohistochemical scores in endometrial cancers. Archives of Gynecology and Obstetrics. 311(5). 1395–1405.
2.
Stögbauer, Fabian, et al.. (2025). Immunohistochemical Profiling of IDO1 and IL4I1 in Head and Neck Squamous Cell Carcinoma: Interplay for Metabolic Reprogramming?. International Journal of Molecular Sciences. 26(8). 3719–3719.
3.
Patil, Akshay, et al.. (2025). Prognostic Value of SOX2 and NANOG Expression in Recurrent Oral Squamous Cell Carcinoma. Cancers. 17(7). 1181–1181.
4.
5.
Ribbat‐Idel, Julika, et al.. (2023). Disseminated ectopic pregnancy after salpingotomy in a 30‐year‐old patient. SHILAP Revista de lepidopterología. 11(4). e7160–e7160. 1 indexed citations
6.
Zimpfer, Annette, et al.. (2023). Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response. Cancers. 15(23). 5597–5597. 6 indexed citations
7.
Ribbat‐Idel, Julika, Dirk Rades, Anke Leichtle, et al.. (2023). TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC. International Journal of Molecular Sciences. 24(6). 5140–5140. 6 indexed citations
8.
Perner, Sven, et al.. (2022). Deglycosylation of pathological specimens alters performance of diagnostic PDL1 antibodies. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(3). 443–451. 6 indexed citations
9.
Idel, Christian, Julika Ribbat‐Idel, Rosemarie Krupar, et al.. (2021). Spatial Distribution of Immune Cells in Head and Neck Squamous Cell Carcinomas. Frontiers in Oncology. 11. 712788–712788. 7 indexed citations
10.
Rades, Dirk, Julika Ribbat‐Idel, Sven Perner, et al.. (2021). A New Survival Score for Patients Scheduled for Palliative Irradiation of Locally Advanced Carcinoma of the Head-and-Neck. Anticancer Research. 41(6). 3055–3058. 1 indexed citations
11.
Ribbat‐Idel, Julika, Rosemarie Krupar, Anne Offermann, et al.. (2021). Performance of Different Diagnostic PD-L1 Clones in Head and Neck Squamous Cell Carcinoma. Frontiers in Medicine. 8. 640515–640515. 16 indexed citations
12.
Idel, Christian, Julika Ribbat‐Idel, Rosemarie Krupar, et al.. (2020). EVI1 as a Marker for Lymph Node Metastasis in HNSCC. International Journal of Molecular Sciences. 21(3). 854–854. 19 indexed citations
13.
Idel, Christian, Julika Ribbat‐Idel, Dirk Rades, et al.. (2020). CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC. International Journal of Molecular Sciences. 21(15). 5508–5508. 7 indexed citations
14.
Ribbat‐Idel, Julika, Karl‐Ludwig Bruchhage, Dirk Rades, et al.. (2020). NR2F6 as a Prognostic Biomarker in HNSCC. International Journal of Molecular Sciences. 21(15). 5527–5527. 15 indexed citations
15.
Köster, Frank, Friederike Hoellen, Julika Ribbat‐Idel, et al.. (2020). PSMD9 expression correlates with recurrence after radiotherapy in patients with cervical cancer. Oncology Letters. 20(1). 581–588. 11 indexed citations
16.
Laban, Simon, Romain Remark, Christian Idel, et al.. (2020). CD3 and CD20 immune cell densities in primary tumors, lymph node metastasis, and recurrent disease samples of head and neck squamous cell carcinoma.. Journal of Clinical Oncology. 38(15_suppl). 6551–6551. 1 indexed citations
17.
Hupe, Marie C., Doris Roth, Christiane Kuempers, et al.. (2019). Using PSMA (prostate-specific membrane antigen) evaluation on prostate biopsies for risk stratification at time of initial diagnosis.. Journal of Clinical Oncology. 37(7_suppl). 6–6. 3 indexed citations
18.
Hupe, Marie C., Doris Roth, Christiane Kümpers, et al.. (2018). Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis. Frontiers in Oncology. 8. 623–623. 115 indexed citations
19.
Offermann, Anne, Christiane Kuempers, Julika Ribbat‐Idel, et al.. (2017). Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups. Frontiers in Medicine. 4. 157–157. 26 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinbo Yue Breakdown of academic impact, for papers by Thore Thiesler Breakdown of academic impact, for papers by Roshal R. Patel Breakdown of academic impact, for papers by Austin Doyle Breakdown of academic impact, for papers by Ping Han Breakdown of academic impact, for papers by Qingting Huang Breakdown of academic impact, for papers by Daniel Buergy Breakdown of academic impact, for papers by Kensei Nakata Breakdown of academic impact, for papers by Mayra Ramos Breakdown of academic impact, for papers by Ghassan Allo
Rankless by CCL
2026